| 000 | 01110nam a2200361 i 4500 | ||
|---|---|---|---|
| 999 |
_c12801 _d12801 |
||
| 001 | 18135500 | ||
| 005 | 20210304102027.0 | ||
| 008 | 880606s1989 nyua b 001 0 eng c | ||
| 010 | _a88-42830 | ||
| 020 | _a088167463X | ||
| 035 | _a4318216 | ||
| 040 |
_aDNLM/DLC _cDLC _dOSU _erda |
||
| 050 |
_aHD9665.5 _b.S68 1989 |
||
| 050 | 0 | 0 |
_aHD9665.5 _b.S68 1989 |
| 060 | _aQV 736 S756m | ||
| 082 | 0 | 0 |
_222 _a615.1 _bS.B.M |
| 100 | 1 |
_aSpilker, Bert _eauthor. |
|
| 245 | 1 | 0 |
_aMultinational drug companies : _bissues in drug discovery and development / _cBert Spilker |
| 264 | 1 |
_aNew York : _bRaven Press, _cc1989 |
|
| 264 | 4 | _cc1989 | |
| 300 |
_axxvi, 606 pages : _billustrations ; _c26 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 500 | _aIncludes index | ||
| 504 | _aBibliography: p. 569-582 | ||
| 650 | 0 | _aPharmaceutical industry | |
| 650 | 0 |
_aPharmaceutical industry _xTechnological innovations |
|
| 650 | 0 |
_aDrugs _xResearch _xManagement |
|
| 650 | 0 | _aInternational business enterprises | |
| 942 |
_2ddc _cBK |
||